-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.5

Benzinga·08/26/2025 10:07:54
Listen to the news
Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $4.5.